Insulin aspart, recombinant Subcutaneous and Renflexis Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Renflexis Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: infliximab
Brand name: Inflectra, Remicade, Renflexis
Synonyms: Renflexis
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Reno Capsules
- Insulin aspart, recombinant Subcutaneous-Reno-30
- Insulin aspart, recombinant Subcutaneous-Reno-60
- Insulin aspart, recombinant Subcutaneous-Reno-Dip
- Insulin aspart, recombinant Subcutaneous-RenoCal-76
- Insulin aspart, recombinant Subcutaneous-Renografin-60
- Renflexis Intravenous-Insulin degludec
- Renflexis Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Renflexis Intravenous-Insulin Degludec (U-100) Vials
- Renflexis Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Renflexis Intravenous-Insulin degludec and liraglutide
- Renflexis Intravenous-Insulin degludec and liraglutide Subcutaneous